ARBUTUS BIOPHARMA CORP's ticker is ABUS and the CUSIP is 03879J100. A total of 66 filers reported holding ARBUTUS BIOPHARMA CORP in Q3 2020. The put-call ratio across all filers is 1.33 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $31,805 | -79.6% | 13,650 | -65.9% | 0.00% | – |
| Q4 2021 | $156,000 | +56.0% | 40,014 | +33.9% | 0.00% | -100.0% |
| Q1 2021 | $100,000 | -82.9% | 29,880 | -90.7% | 0.00% | -88.9% |
| Q2 2020 | $586,000 | +1262.8% | 322,225 | +662.8% | 0.01% | +800.0% |
| Q1 2020 | $43,000 | -68.6% | 42,243 | -35.8% | 0.00% | 0.0% |
| Q2 2019 | $137,000 | +104.5% | 65,848 | +395.1% | 0.00% | 0.0% |
| Q1 2018 | $67,000 | -2.9% | 13,300 | -2.2% | 0.00% | 0.0% |
| Q4 2017 | $69,000 | +7.8% | 13,600 | +32.0% | 0.00% | 0.0% |
| Q3 2017 | $64,000 | +93.9% | 10,300 | -23.1% | 0.00% | 0.0% |
| Q4 2016 | $33,000 | – | 13,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 3,705,128 | $10,300,000 | 4.44% |
| RTW INVESTMENTS, LP | 5,666,754 | $15,754,000 | 0.59% |
| COWEN AND COMPANY, LLC | 926,200 | $2,575,000 | 0.22% |
| Hudson Bay Capital Management LP | 850,000 | $2,363,000 | 0.05% |
| LADENBURG THALMANN FINANCIAL SERVICES INC. | 1,774,915 | $4,934,000 | 0.03% |
| Point72 Asset Management, L.P. | 1,897,284 | $5,274,000 | 0.03% |
| 683 Capital Management, LLC | 77,368 | $215,000 | 0.02% |
| Secure Asset Management, LLC | 10,000 | $28,000 | 0.02% |
| Qube Research & Technologies Ltd | 166,138 | $462,000 | 0.01% |
| Verition Fund Management LLC | 174,455 | $485,000 | 0.01% |